Evidence map›Paper›PMID 42193924›Full record

ArticleCells2026

Preliminary Analysis of the Proportion and Characteristics of Dual BCR B Cells in SLE Model Mice and Patients via scRNA-Seq Combined with scBCR-Seq Technology.

Kai Quan, Hongxia Yang, Guangtian Tang, Ziwei Li, Hailin Zou, Jing Ma, Xinsheng Yao

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kai QuanDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Hongxia YangDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Guangtian TangDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Ziwei LiDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Hailin ZouDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Jing MaDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.
Xinsheng YaoDepartment of Immunology, Zunyi Medical University, Zunyi 563000, China.ORCID 0000-0001-6960-4003

Funding

Guizhou Provincial Science and Technology Department No. (2018)5637National Natural Science Foundation of China 82471630
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune dysregulation and multi-organ damage. Abnormal B cell activation and autoantibody production constitute the core pathological mechanism of SLE. However, the proportion, BCR pairing types, clonal evolution patterns, and transcriptomic features of dual BCR B cells in SLE remain incompletely elucidated. In this study, we employed single-cell RNA sequencing (scRNA-seq) combined with single-cell B cell receptor repertoire sequencing (scBCR-seq) to preliminarily analyze the proportion and characteristics of dual BCR B cells in SLE model mice (MRL/Lpr and SLE.Yaa) as well as in peripheral blood from SLE patients. The results showed: (1) Compared with control groups, the proportion of dual BCR B cells in SLE model mice and patients exhibited a decreasing trend, whereas the diversity of the CDR3 repertoire decreased and clonality increased. Increased clonal sharing was observed between single BCR B cells and dual BCR B cells. The main pairing types of dual BCR B cells were H + κ1 + κ2, H1 + H2 + κ, and H1 + H2 + κ + λ, with preferential utilization of autoimmunity-associated V gene families such as

Indexed as

B-LymphocytesLupus Erythematosus, SystemicReceptors, Antigen, B-CellRNA-SeqSingle-Cell AnalysisAnimalsDisease Models, AnimalFemaleHumansMaleMiceReceptors, Antigen, B-CellBCR CDR3 repertoiredual BCR B cellssingle-cell RNA sequencingsingle-cell VDJ (BCR) sequencingsystemic lupus erythematosus (SLE)

Identifiers

PMID42193924
PMCPMC13204964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.